Email this article Small cell prostate cancer: a clinical case
- Authors: Ivanov A.M.1, Skvortsov I.Y.2, Delektorskaya V.V.2, Gorbunova V.A.2
-
Affiliations:
- MEDSIgroup, Clinical Hospital 2
- N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
- Issue: Vol 15, No 1 (2019)
- Pages: 131-136
- Section: CLINICAL CASE
- Published: 30.03.2019
- URL: https://oncourology.abvpress.ru/oncur/article/view/865
- DOI: https://doi.org/10.17650/1726-9776-2019-15-1-131-136
- ID: 865
Cite item
Full Text
Abstract
Small cell cancer of the prostate is extremely rare. No sound on the research recommendations for the treatment of patients with small cell cancer of the prostate. The article gives its own observation of the patient’s small cell cancer of the prostate. A discussion of possible methods to treat such patients using own results and literature data.
About the authors
A. M. Ivanov
MEDSIgroup, Clinical Hospital 2
Author for correspondence.
Email: doc-ivanov@bk.ru
5 2nd Botkinskiy Proezd, Moscow 125284
Russian FederationI. Ya. Skvortsov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Email: igorsammi@mail.ru
23 Kashirskoe Shosse, Moscow 115478
Russian FederationV. V. Delektorskaya
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
23 Kashirskoe Shosse, Moscow 115478
Russian FederationV. A. Gorbunova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Email: igorsammi@mail.ru
23 Kashirskoe Shosse, Moscow 115478
Russian FederationReferences
- Small E.J., Huang J., Youngren J. et al. Characterization of neuroendocrine prostate cancer in patients with metastatic castration resistant prostate cancer resistant to abiraterone or enzalutamide: preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team. J Clin Oncol 2015;33(suppl):abstr 5003.
- Galanis E., Frytak S., Lloyd R.V. Extrapulmonary small cell carcinoma. Cancer 1997;79(9):1729 — 36. PMID: 9128989.
- Helpap B., Kollermann J., Oehler U. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol Int 1999;62(3):133—8. doi: 10.1159/000030376. PMID: 10529661.
- Wenk R.E., Bhagavan B.S., Levy R. et al. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer 1977;40(2):773-8. PMID: 196743.
- Skvortsov I.Ya., Kamo-lov B.Sh., Khafizov K.O. et al. Neuroendocrine carcinoma of the prostate: a case report. Onkourologiya = Cancer Urology 2011;(2):92—5. (In Russ.).
- Oesterling J.E., Hauzeur C.G., Farrow G.M. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and im-munohistological study of 27 patients. J Urol;147(3 Pt 2):804-7. PMID: 1311395.
- Tetu B., Ro J.Y., Ayala A.G. et al. Small cell carcinoma of the prostate. Pt I. A clin-icopathologic study of 20 cases. Cancer 1987;59(10):1803—9. PMID: 3030528.
- Palmgren J.S., Karavadia S.S., Wakefield M.R. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol 2007;34(1):22-9. doi: 10.1053/j.seminoncol.2006.10.026. PMID: 17270662.
- Cristopher М.Е., Seftel A.D., Sorenson K., Resnick M.I. Small cell carcinoma of the genitourinary tract: an immunohistochem-ical, electron microscopic and clinico-pathological study. J Urol 1991;146(2):382—8. PMID: 1713277.
- NCCN Clinical Practice Guidelines: Prostate Cancer. Version 1.2016.
- Aparicio A.M., Harzstark A.L., Corn P.G. et al. Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res 2013;19(13):3621-30. doi: 10.1158/1078-0432.CCR-12-3791. PMID: 23649003.
- Aggarwal R., Huang J., Alumkal J.J. et al. Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multiinstitutional prospective study. Clin Oncol 2016;34(suppl 2S):abstr 288. DOI: org/10.1200/JCO.2017.77.6880.
Supplementary files
